Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities.It was founded in 2010 and headquartered in Menlo Park, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 19, 2014 | Series C | $51M | 1 | — | — | Detail |